- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04046393
Investigating the Effect of Herbal Medicine Nasal Irrigation on Treatment of Chronic Rhinitis and Sinusitis
Chia Yi Chang Gung Memorial Hospital
Study Overview
Status
Conditions
Detailed Description
In the program, the investigators plan to investigate a clinical triad to research the outcomes of nasal irrigation with Traditional herbal medicine extract-saline isotonic solution for treatment of chronic rhinitis and sinusitis. The aims of this study are listed below:
Aim 1: evaluating the outcomes and quality of life of nasal irrigation with Traditional herbal medicine extract-saline isotonic solution to treat enrolled patients with chronic rhinitis or sinusitis. The investigators use modern devices to evaluate the autonomic nerve, meridian energy and pulse. The questionnaires of quality of life and symptoms will be recorded. Nasal irrigation with saline alone will be conducted during the clinical triad to compare the effectiveness and quality of life with Traditional herbal medicine extract.
Aim 2: analyzing the changes of bacteria culture in nasal discharge collected during the clinical triad before and after nasal irrigation for investigating the microenvironment of Traditional herbal medicine extract-saline isotonic solution.
According to the research, the investigators will realize the improvement of using Traditional herbal medicine extract-saline isotonic solution for nasal irrigation to treat sino-nasal diseases, by investigating the changes of quality of life and microenvironment of nasal cavity. The nasopharyngoscopic examination, autonomic nerve, meridian energy and pulse were record to compare the effectiveness of Traditional herbal medicine extract-saline isotonic solution with nasal irrigation with saline alone.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Chiayi City, Taiwan
- Recruiting
- Chang Gung Memorial Hospital
-
Contact:
- Pei-Rung Yang
- Phone Number: 2069 +886-5-3621000
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnostic criteria for chronic rhinitis and sinusitis male and female volunteers.
- Stop using oral and topical steroid and anti-histamine treatments >2 weeks prior to enrollment.
- >20 years of age.
Exclusion Criteria:
- Allergy to herbal medicine.
- Presence of a sinus tumor.
- Significant immune dysfunction.
- Pregnancy and breast-feeding women.
- Undergone nasal surgery <1 week prior to enrollment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Traditional Chinese Medicine(TCM) group
nasal irrigation with Traditional herbal medicine(licorice) extract-saline isotonic solution
|
measure autonomic nerve
measure meridian energy
use culture swab to culture nasal discharge
use nasopharyngoscopy to determine the modified Lund-Kennedy endoscopic scoring system
Chinese herbal medicine (licorice) extract solution with buffered salt packet and water in rinse bottle
|
|
Placebo Comparator: Saline control group
nasal irrigation with saline isotonic solution
|
measure autonomic nerve
measure meridian energy
use culture swab to culture nasal discharge
use nasopharyngoscopy to determine the modified Lund-Kennedy endoscopic scoring system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WHOQOL-brief score (Taiwan version)
Time Frame: one month
|
consisting of 28 items, each scored from 1 to 5; total score recorded as the sum of all items change from baseline: the questionnaires of quality of life
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
22-item Sino-Nasal Outcome Test score (SNOT-22)
Time Frame: one month
|
consisting of 22 items, each scored from 0 to 5; total score recorded as the sum of all items, 0 to 110 change from baseline: the questionnaires of chronic sinusitis severity
|
one month
|
|
Total symptom score(TSS)
Time Frame: one month
|
consisting of 4 items, each scored from 0 to 3; total score recorded as the sum of all items, 0 to 12 change from baseline: the questionnaires of chronic rhinitis severity
|
one month
|
|
Autonomic nerve (HRV)
Time Frame: one month
|
Low frequency (ms2), High frequency (ms2), LF/HF(indicate autonomic function) change from baseline
|
one month
|
|
Meridian energy
Time Frame: one month
|
Yang energy and Yin energy change from baseline
|
one month
|
|
Posttreatment culture negativity
Time Frame: one month
|
negative" means if no bacterial pathogen is identified on posttreatment culture but at least one has been present on pretreatment culture
|
one month
|
|
Nasopharyngoscopic examination change
Time Frame: one month
|
consisting of 3 items, each scored from 0 to 2; total score recorded as the sum of both side all items, 0 to 12 change from baseline
|
one month
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Pei-Rung Yang, Chang Gung Memorial Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201801970A3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nasal Disease
-
Omnivium Pharmaceuticals LLCNot yet recruitingNasal Procedures | Nasal Anesthesia | Nasal Mucosa Surgery
-
C.O.C. Farmaceutici S.r.l.CompletedNasal Congestion | Nasal DrynessItaly
-
Kafrelsheikh UniversityNot yet recruitingNasal Septum; Deviation | Nasal Septal Srur
-
BioplusAsan Medical Center; Seoul National University Hospital; Soonchunhyang University...Enrolling by invitationNasal Surgery | Nasal DiseaseKorea, Republic of
-
Nano PharmaSolutions AustraliaCMAX Clinical Research Pty Limited; Beyond Drug DevelopmentCompletedTolerability of NT-301 Nasal Spray | Pharmacokinetics of NT-301 Nasal Spray | Safety of NT-301 Nasal Spray | Performance of NT-301 Nasal Spray DeviceAustralia
-
Noden PharmaOmnivium Pharmaceuticals LLC; LXO GroupRecruitingENT Disorder | Nasal Procedures | Nasal Anesthesia | Nasal Mucosa SurgeryUnited States
-
St. Paul's Sinus CentreNot yet recruitingChronic Rhinosinusitis (Diagnosis), Nasal Polyposis | CRSwNPCanada
-
Assiut UniversityRecruitingAnalgesia During Removal of Nasal Pack After Nasal SurgeryEgypt
-
Indonesia UniversityNot yet recruitingNasal Mask | Nasal Prong
-
Region SkaneRecruitingChronic Rhinosinusitis With Nasal Polyps | Chronic Rhinosinusitis Without Nasal PolypsSweden
Clinical Trials on Taiwan Scientific" noninvasive blood pressure meter TS-0411
-
Taichung Tzu Chi HospitalUnknownBarrett's Esophagus | Non-erosive Reflux DiseaseTaiwan